Trials / Conditions / Non-small Cell Lung Cancer Stage ⅢA
Non-small Cell Lung Cancer Stage ⅢA
5 registered clinical trials studyying Non-small Cell Lung Cancer Stage ⅢA — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Neoadjuvant Chemoimmunotherapy in Stage IIIA- N2IIIB Non-small Cell Lung Cancer NCT06394427 | West China Hospital | — |
| Active Not Recruiting | Clinical Study of Neoadjuvant Chemotherapy and Immunotherapy Combined With Probiotics in Patients With Resecta NCT04699721 | Xiangya Hospital of Central South University | Phase 2 |
| Withdrawn | Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer NCT03628144 | H. Lee Moffitt Cancer Center and Research Institute | Phase 2 |
| Unknown | Neoadjuvant Therapy of Pembrolizumab + Ramucirumab for PD-L1 Positive Stage IB-IIIA Lung Cancer (EAST ENERGY) NCT04040361 | Masahiro Tsuboi | Phase 2 |
| Unknown | Clinical Observation of S1 Capsule for Stage Ⅱ-ⅢA Non-small Cell Lung Cancer After Complete Resection NCT02223611 | Hebei Medical University Fourth Hospital | Phase 2 |